Neumora Therapeutics, Inc.盘中异动早盘大幅下跌5.92%报0.660美元

市场透视05-19

北京时间2025年05月19日21时31分，Neumora Therapeutics, Inc.（NMRA.us）股票出现波动，股价急速下挫5.92%。截至发稿，该股报0.660美元/股，成交量8175股，换手率0.01%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-67.99百万美元，每股收益-0.42美元，毛利-157000.00美元，市盈率-0.42倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2536680895?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-19 21:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2536680895","market":"us","top_or_hot":-1,"title":"Neumora Therapeutics, Inc.盘中异动 早盘大幅下跌5.92%报0.660美元","media":"市场透视","content":"<div>\n<p>北京时间2025年05月19日21时31分，Neumora Therapeutics, Inc.（NMRA.us）股票出现波动，股价急速下挫5.92%。截至发稿，该股报0.660美元/股，成交量8175股，换手率0.01%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-67.99百万美元，每股收益-0.42美元，毛利-157000.00美元，市盈率-0.42倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051921313394fb92d1&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Neumora Therapeutics, Inc.盘中异动 早盘大幅下跌5.92%报0.660美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNeumora Therapeutics, Inc.盘中异动 早盘大幅下跌5.92%报0.660美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-19 21:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051921313394fb92d1&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年05月19日21时31分，Neumora Therapeutics, Inc.（NMRA.us）股票出现波动，股价急速下挫5.92%。截至发稿，该股报0.660美元/股，成交量8175股，换手率0.01%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-67.99百万美元，每股收益-0.42美元，毛利-157000.00美元，市盈率-0.42倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051921313394fb92d1&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NMRA","symbol_name":"Neumora Therapeutics, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051921313394fb92d1&s=b","article_id":"2536680895","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051921313394fb92d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2536680895","pubTimestamp":1747661493,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年05月19日21时31分，Neumora Therapeutics, Inc.股票出现波动，股价急速下挫5.92%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，成立的初衷是通过采用一种全新的方法来开发脑部疾病治疗方案，以应对脑部疾病危机。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"NMRA":"Neumora Therapeutics, Inc.","BK4139":"生物科技","LENZ":"Therapeutics","BK4007":"制药","BK4539":"次新股"},"translate_title":"Neumora Therapeutics, Inc. Intraday Move Sharp 5.92% to $0.660 in Morning Trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NMRA":1,"LENZ":1},"content_text":"北京时间2025年05月19日21时31分，Neumora Therapeutics, Inc.（NMRA.us）股票出现波动，股价急速下挫5.92%。截至发稿，该股报0.660美元/股，成交量8175股，换手率0.01%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-67.99百万美元，每股收益-0.42美元，毛利-157000.00美元，市盈率-0.42倍。机构评级方面，在所有8家参与评级的机构中，38%的券商给予买入建议，62%的券商给予持有建议，无券商给予卖出建议。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，Protagenic Therapeutics, Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 (To Pur Com)、Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)涨幅较大，Polyrizon Ltd.、Protagenic Therapeutics, Inc.、Nucana Plc较为活跃，换手率分别为6929.99%、4214.61%、1957.15%，振幅较大的相关个股有再鼎医药、奥麦罗制药、Corvus Pharmaceuticals, Inc.，振幅分别为105.85%、100.16%、99.75%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，成立的初衷是通过采用一种全新的方法来开发脑部疾病治疗方案，以应对脑部疾病危机。该公司已扩大其治疗产品线，目前包括七个临床和临床前神经科学项目，旨在针对一系列未得到充分治疗的神经精神障碍和神经退行性疾病的新型作用机制。其产品包括 NMRA-140、NMRA-511、NMRA-266、NMRA-M4R、NMRA-NMDA、NMRA-CK1O、NMRA-NLRP3 和 NMRA-GCASE。该集团的产品线正在构建针对未得到充分治疗的神经精神障碍和神经退行性疾病的项目。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2536680895","isCrawlerRequest":true}

Neumora Therapeutics, Inc.盘中异动 早盘大幅下跌5.92%报0.660美元

精彩评论

Neumora Therapeutics, Inc.盘中异动早盘大幅下跌5.92%报0.660美元